Hematopoietic cell transplantation in adults with acute myeloid leukemia: A review of the results from various nationwide registry studies in Japan.
acute myeloid leukemia
allogeneic transplantation
autologous transplantation
hematopoietic cell transplantation
registry study
Journal
Blood cell therapy
ISSN: 2432-7026
Titre abrégé: Blood Cell Ther
Pays: Japan
ID NLM: 9918333884906676
Informations de publication
Date de publication:
25 May 2021
25 May 2021
Historique:
received:
22
12
2020
accepted:
10
02
2021
entrez:
30
1
2023
pubmed:
2
4
2021
medline:
2
4
2021
Statut:
epublish
Résumé
Hematopoietic cell transplantation (HCT) is an integral part of the treatment of acute myeloid leukemia (AML). Although AML is the most common indication for allogeneic HCT, the relatively small number of patients and the highly complex nature of the procedure often render prospective studies on HCT unfeasible. Observational studies using registry data serve as important sources of information under such circumstances. Thus, the Japanese Society of Hematopoietic Cell Transplantation (JSHCT) has been conducting a nationwide survey of HCT since 1993, and this registration program now covers >99% of transplantation centers in Japan. A constant increase in the number of HCT procedures has been noted with recent annual registrations recording more than >1,000 new AML patients undergoing allogeneic or autologous HCT. Since its establishment in 2010, the Adult AML Working Group within the JSHCT has been using this registry data to complete several studies focusing on various aspects of HCT in adults with AML, with particular attention paid to patient-, disease-, and transplantation-related factors. This article comprehensively reviews the results obtained from these studies and discusses the strengths and limitations of these kinds of registry-based studies.
Identifiants
pubmed: 36712900
doi: 10.31547/bct-2020-023
pmc: PMC9847311
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
35-43Informations de copyright
Copyright Ⓒ2021 APBMT. All Rights Reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. Disclosure forms provided by the authors are available here.
Références
Leuk Lymphoma. 2018 Mar;59(3):601-609
pubmed: 28750566
J Hematol Oncol. 2015 Sep 04;8:102
pubmed: 26337829
Haematologica. 2018 Feb;103(2):e69-e72
pubmed: 29146707
Ann Hematol. 2016 Jan;95(2):295-300
pubmed: 26499506
Br J Haematol. 2018 Jul;182(2):245-250
pubmed: 29808919
Biol Blood Marrow Transplant. 2020 Mar;26(3):463-471
pubmed: 31562960
Biol Blood Marrow Transplant. 2017 Sep;23(9):1447-1454
pubmed: 28533061
Blood. 2015 Jul 16;126(3):415-22
pubmed: 26031916
Biol Blood Marrow Transplant. 2014 Nov;20(11):1785-90
pubmed: 25034960
Bone Marrow Transplant. 2021 Feb;56(2):387-394
pubmed: 32796950
Biol Blood Marrow Transplant. 2017 Aug;23(8):1398-1404
pubmed: 28455005
Am J Hematol. 2016 Mar;91(3):302-7
pubmed: 26663096
Bone Marrow Transplant. 2013 Mar;48(3):390-5
pubmed: 22941379
Biol Blood Marrow Transplant. 2014 Dec;20(12):2029-33
pubmed: 25196856
Ann Hematol. 2017 Mar;96(3):469-478
pubmed: 28058493
Leuk Res. 2016 Aug;47:47-53
pubmed: 27244257
Biol Blood Marrow Transplant. 2019 Jan;25(1):e23-e27
pubmed: 30103016
Bone Marrow Transplant. 2020 Oct;55(10):2008-2016
pubmed: 32203266
Bone Marrow Transplant. 2017 Jun;52(6):818-824
pubmed: 28112749
Int J Hematol. 2020 Jan;111(1):93-102
pubmed: 31612307
Ann Hematol. 2019 Sep;98(9):2179-2186
pubmed: 31203422
Ann Hematol. 2018 Nov;97(11):2173-2183
pubmed: 29978286
Bone Marrow Transplant. 2019 Dec;54(12):2004-2012
pubmed: 31152148
Leuk Lymphoma. 2017 May;58(5):1061-1067
pubmed: 27701911
Blood. 2005 Oct 15;106(8):2912-9
pubmed: 15994282
Biol Blood Marrow Transplant. 2016 Dec;22(12):2208-2213
pubmed: 27667010
Lancet. 1998 Oct 3;352(9134):1087-92
pubmed: 9798583
Bone Marrow Transplant. 2019 Nov;54(11):1789-1798
pubmed: 31068659
Bone Marrow Transplant. 2016 May;51(5):645-53
pubmed: 26808566
Ann Hematol. 2017 Feb;96(2):289-297
pubmed: 27838773
Int J Hematol. 2016 Jan;103(1):3-10
pubmed: 26547570
Biol Blood Marrow Transplant. 2019 Sep;25(9):1730-1743
pubmed: 31054982
Bone Marrow Transplant. 2019 Apr;54(4):578-586
pubmed: 30108330
Bone Marrow Transplant. 2016 Apr;51(4):604-6
pubmed: 26642343
Biol Blood Marrow Transplant. 2020 Feb;26(2):307-315
pubmed: 31605818
Am J Hematol. 2019 Jan;94(1):103-110
pubmed: 30370944
Bone Marrow Transplant. 2020 Jan;55(1):249-252
pubmed: 30971777
Leuk Lymphoma. 2019 Jun;60(6):1493-1502
pubmed: 30457400
Ann Hematol. 2020 Jun;99(6):1351-1360
pubmed: 32363416
Bone Marrow Transplant. 2020 Oct;55(10):1955-1965
pubmed: 32203256